We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women.
- Authors
Markowska, Anna; Antoszczak, Michał; Markowska, Janina; Huczyński, Adam
- Abstract
Statins, also known as HMG-CoA inhibitors, are a class of bioactive small molecules that efficiently reduce the levels of cholesterol, and therefore are commonly used to manage and prevent various cardiovascular diseases. With respect to their original medical indications, statins are currently in the group of the most prescribed drugs worldwide. Of note is that statins are perceived actually rather as agents that have pleiotropic activities; in addition to their inhibitory activity on the production of endogenous cholesterol. Statins may also affect cell proliferation, angiogenesis and/or migration (metastasis) of different cancer cells, and play a positive role in the chemoprevention of cancer, thus being the excellent candidates to be repurposed in oncology. Particularly intriguing in this context seems to be the promising role of statins on both the incidence and course of common malignant neoplasms in women. In this article, we review and discuss the effect of the use of statins in the treatment of three types of cancer, i.e., breast, endometrial and ovarian cancer, with the highest mortality among gynecological cancers.
- Subjects
REDUCTASE inhibitors; STATINS (Cardiovascular agents); ANTINEOPLASTIC agents; TUMORS; CANCER chemoprevention; BREAST
- Publication
Pharmaceuticals (14248247), 2020, Vol 13, Issue 12, p422
- ISSN
1424-8247
- Publication type
Article
- DOI
10.3390/ph13120422